54256-41-6 Usage
General Description
BUTOXYCARBONYLAMINO-CYCLOPROPYL-ACETIC ACID is a chemical compound with the molecular formula C14H23NO5. It is a derivative of cyclopropyl acetic acid and contains a butoxycarbonylamine group. BUTOXYCARBONYLAMINO-CYCLOPROPYL-ACETIC ACID is used in the development and synthesis of pharmaceuticals and agrochemicals. It has been studied for its potential as an inhibitor of the enzyme dihydroorotate dehydrogenase, which plays a role in the biosynthesis of pyrimidine nucleotides. Additionally, it may have applications in medicinal chemistry for the treatment of various diseases. Further research is needed to fully understand the properties and potential uses of BUTOXYCARBONYLAMINO-CYCLOPROPYL-ACETIC ACID.
Check Digit Verification of cas no
The CAS Registry Mumber 54256-41-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,4,2,5 and 6 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 54256-41:
(7*5)+(6*4)+(5*2)+(4*5)+(3*6)+(2*4)+(1*1)=116
116 % 10 = 6
So 54256-41-6 is a valid CAS Registry Number.
54256-41-6Relevant articles and documents
Synthesis of cyclopropane-containing building blocks via Ir-catalyzed enantioselective allylic substitution reaction
Xia, Jibao,Zhuo, Chunxiang,You, Shuli
, p. 1525 - 1528 (2010)
Chiral cyclopropane-containing building blocks, which are very important synthetic intermediates for natural products or pharmaceuticals, were easily synthesized via Ir-catalyzed enantioselective allylic substitution reaction.
Substituted Pyrrolidine Amides II
-
Paragraph 0393-0395, (2019/07/03)
The invention relates to compounds according to general formula (I), which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.
CERTAIN 1-(D-CYCLOPROPYLGLYCINYL)-4-(PIPERIDIN-4-YL)PIPERAZINE COMPOUNDS AS INHIBITORS OF THE SERINE PROTEASE FACTOR XA
-
Page/Page column 10, (2008/06/13)
The compounds of formula (I) in which R represents a hydrogen atom or a fluorine atom, or a pharmaceutically acceptable salt thereof are Factor Xa inhibitors useful in the treatment of thrombotic disorders.